Document Preview Unavailable
Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study
Yu‐Shan Huang; Ming‐Feng Li; Mei‐Chen Lin; Shih‐Hsiang Ou; Jen‐Hung Wang; et al. Clinical and Translational Science Vol. 15, Iss. 9, (Sep 2022): 2195-2205.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




